TITLE:
Selegiline in Outpatient Treatment for Cocaine Dependence - 1

CONDITION:
Cocaine-Related Disorders

INTERVENTION:
Selegiline

SUMMARY:

      The purpose of this study is to evaluate the efficacy and clinical safety of selegiline in
      the treatment of cocaine dependence and to assess neurotoxicity (Magnetic Resonance Imaging,
      MRI) post-hoc as a possible variable for future stratification in clinical trials.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 21 Years to 50 Years
Criteria:

        Inclusion Criteria:

        M/F ages 21-50. Meets DSM-IV criteria for cocaine. Agreeable to conditions of study and
        signed informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical conditions that deem participation to be unsafe.
      
